Zinner NR - Search Results

1

Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients.

Zinner NR, Mattiasson A, Stanton SL. Zinner NR, et al. J Am Geriatr Soc. 2002 May;50(5):799-807. doi: 10.1046/j.1532-5415.2002.50203.x. J Am Geriatr Soc. 2002. PMID: 12028164 Clinical Trial.

2

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

Van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A; Tolterodine Study Group. Van Kerrebroeck P, et al. Urology. 2001 Mar;57(3):414-21. doi: 10.1016/s0090-4295(00)01113-4. Urology. 2001. PMID: 11248608 Clinical Trial.

3

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.

Zinner NR, Dmochowski RR, Staskin DR, Siami PF, Sand PK, Oefelein MG. Zinner NR, et al. Neurourol Urodyn. 2011 Sep;30(7):1214-9. doi: 10.1002/nau.21000. Epub 2011 Apr 1. Neurourol Urodyn. 2011. PMID: 21462240

4

Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER.

Zinner N, Noe L, Rasouliyan L, Marshall T, Seifeldin R. Zinner N, et al. Curr Med Res Opin. 2008 Jun;24(6):1583-91. doi: 10.1185/03007990802081766. Epub 2008 Apr 17. Curr Med Res Opin. 2008. PMID: 18423103 Clinical Trial.

5

Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.

Zinner N, Tuttle J, Marks L. Zinner N, et al. World J Urol. 2005 Sep;23(4):248-52. doi: 10.1007/s00345-005-0507-3. Epub 2005 Nov 8. World J Urol. 2005. PMID: 16096831 Clinical Trial.

6

Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P; International Continence Society. Schäfer W, et al. Among authors: zinner nr. Neurourol Urodyn. 2002;21(3):261-74. doi: 10.1002/nau.10066. Neurourol Urodyn. 2002. PMID: 11948720

7

Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder.

Zinner NR. Zinner NR. Expert Opin Pharmacother. 2005 Jul;6(8):1409-20. doi: 10.1517/14656566.6.8.1409. Expert Opin Pharmacother. 2005. PMID: 16013990 Review.

8

Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: an investigation of warning time in patients with OAB.

Zinner N, Susset J, Gittelman M, Arguinzoniz M, Rekeda L, Haab F. Zinner N, et al. Int J Clin Pract. 2006 Jan;60(1):119-26. doi: 10.1111/j.1368-5031.2005.00770.x. Int J Clin Pract. 2006. PMID: 16409440 Clinical Trial.

9

Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy.

Zinner N, Kobashi KC, Ebinger U, Viegas A, Egermark M, Quebe-Fehling E, Koochaki P. Zinner N, et al. Int J Clin Pract. 2008 Nov;62(11):1664-74. doi: 10.1111/j.1742-1241.2008.01893.x. Epub 2008 Sep 22. Int J Clin Pract. 2008. PMID: 18811599 Free PMC article. Clinical Trial.

10

Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial.

Zinner N, Gittelman M, Harris R, Susset J, Kanelos A, Auerbach S; Trospium Study Group. Zinner N, et al. J Urol. 2004 Jun;171(6 Pt 1):2311-5, quiz 2435. doi: 10.1097/01.ju.0000127742.73136.0c. J Urol. 2004. PMID: 15126811 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters